R•gl•t•rnd numb•r. 0824091J Charlty nun*. 1149768 ARK CANCER CHARITY (A Company Umltod by Guardntoo) UNAUDrrED TRUSTEES. REPORT AND FINANCIAL STATEIAEKrs FOR THE YEAR ENDED 31 DECEMBER 2023
9-10 B*lanc• She•t 12-13 14-28
AIIK CANCER CHAIUTY (A CoNyny Llm*•d ty Guarants•l REFERE14CE APXI ADIAINI8TRATIVE DETAILS OF THE COMPANY. rrs TRUSTEES AND ADVISER3 FOR THE YEAR EMI 31 DECEMBER 2023 Trn•t• MR9 S Fell. Cha R Firfayson l Hathson {8FWWrted 28 Juno 2023) Company r•glstsr•d numb•r 08240913 ChaY r•gknt•r•d numb•r 1149758 Company ¥•¢r•tary B DevereL¢X Accounlants
ARK CANCER CHARITY TrUSTEES REPORT FOR THE YEAR ENDED 31 DECEAIBER 2023 The Twstees ITkn arg alw direct oftr Ch ky the pws•5 cl tho Co[8•$ wesert thelr nu01 report, Whlch 1$ also the direLorf T•P(rt together the fnwual slatements of Cancer Centre Charity (the company) for the ye 31 December 2023. Tho Twstees confiTh that the Pl7nL1 Report and FinclaI Statemerts of thè company conwy with ts twgnt stalutory reqLIr8Mts. the rerylr•ments of the companfs pverring dOrnent thè proviwn$ of th• Ststement of RecommwKlgJ Prnctre (SORP) "ACoxm9 and Rwirlir¥J by Ch$" 2019). Slnce the Com&wy 8$ small ¥jer 383. th• stra Repyt rewd of methum ond Iwge CnI&S wxler Ihe C¢mpVas kn12(1% {StrG Rff•yt w•J RertI Rogn$ 2013 1$ n¢X requirèd. • Stvuctsr• Ajk Cancer C•ntre Cty is a Limthj ty Guarwkne (No: 8240913) a ¢114ty Registered in Englond arKI W4les {No". 11497S8). ft is gtr4wrwd ty ts MemcrfaThlwn Arbd8s ofAsgocialion. Thg Trustees onstitute Direct oftha Charity forlho FrfXFes ofcoryyany law. Ark Cancèr Centr• was rered as • 41h Octs)bw 2012. ft was r¢pt•r8d as a charity on 14th November 2012 and as a result a0ved to rts r& to Ark Cancer C•ntr8 Charity on 26th November2011 Emrknasis is ed thè sk of to Tnth, f1 to th& Charitys devolopThnL • Manag•mont Th• management of Ch•ity d•thcated to enhanco the expen•nce of cancer pabènts r•caivlng trpatment at Haryshlre HOS1 Fod811 TfttsL Thrw the grants wjhcy. vrt are ablo to fvnd Iho Communution: Tho Trustees IPA Ihe •mB ofth• Clwuy we TAth accur•cy dwity to I Fknanca w#J *Jm1iistrabf". minag8d by the Tmstees. P•J• 2
ARK CAIKER CHARITY IA Coryany LInd ty Gurantsèl TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDELI 31 DECEhER 2023 Stru¢tsre, manag•mont and gov•rnanc• 1Gonlkny) • Gov•manc• The relief of slthnw arnl tt)e weservatk)n ol he1 d to assi in the treaiment KI care of persons afferaad by ¢anCerthr9h the oan¢9m0nts olal aspects of care I19. prwding iy assisting of equ¥Mnthi( f•akIS serv[9 or to WO¢ or 181 in the wovisc¥) of ftm¢thng tr etharKod or imwoved fjtttng c1 and d9Ctyatn or any improvwnent to the a8slh8tie aspects ofnow or eyisting ¢Or ¢gr• caitre¥ run by the statsjtuy authxities ry other care yovidors to enh th& wellbeing of peTron8 affect•d by providlr¥J or as$IK¥j in tr prrmsicffi ot ¢X proVw9 funthg for slatutw aut1111•$ or other car providers lo prowdè. andl•y niOnIary car• wvice8 arKI th9r41i to enha8 the Ihwr carern, familios carers, fames and friends. The furtherance of obieds purpoges to be led in Norlh Hnp8hlre or general in the Lkniled ngdorn being abjocts and PLwwses are exdusivaty chariloble ac£¢qlTr3 l ot England and Wales. 2. Put4c 8Offl The Charlty has looked a ths berffls of ts Ltierves aTrJ has Co1 Ihat there Is 8iwificwrt ovidence htghlighting that offthing treatrnent in a aSant. int•resbn9, irmvatNe environment tnefits patients and gre1 iFrw)¥es tho OLrtcom ottheir Iro The gr¥ts ensuro the provision ofr. Se1 wlhln an ex¢epllonal $8ttwig eTr4ironMI 1p to elevg the psychologlcal W8Uness of patients and thew fami58& EvpJence SubstwaleS thoso •thnlnlstering treatments ¢er trealmenL A range ol wpport therws. i.e. psyocal wpport, WP4tvcthry> ¢ours95, Xcgss lo h8th, frtness. complamaw th8rops. etr. Flus Lp¥ehensive infomatM rescAffces. The8e S&e5 enabl8 patients to mago Iher (wllkn and treatmrtIO assist peoplo livtng with tcer arKI Ihew familie$. In SWIM the putlc benth OlA Cwkni Is lo ensw• thal fxllbes a¥lab for anyone W+tri needs support. ether rKeW or are famity membws gn9agfjd in SLPWn9 a srer dwing or aft& th tra•1mL
ARK CAIKER CHARITY IA Company UMtt by auarnnt••) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 strlUT•. minag•m•rt and gov•m•nc• Icortknwdl Therth tho Trusteos belipve IfAt Itv Iw¥e ccrfnF4&J to have kn rtyard io putltshed by the ConYrriswL Plan• forluthn p•rh)d• the support they need. • Grnnt maklng pomcy Funithng Is madè availat49 to Ha)Wirn Hcryxl NHS Founrjation Tnt via gr•s. Grants arg made to Hamp8hire Hospll NHS Trust at Tnts' (sry01•)n. The Truste 8$58ss an bJs from Hampshke Hos$Nta NHS Fndon Tntst tD er? tyt the Charty wc¥Jld not b• $LsbstitutAVJ Olher fvTrJiTrJ sources for stanuafd pro¥ion but be c<Yrtn"tsJtsry to enhanLYThJ 1$ &XkCted tw abo¥• that T•hKti V•ill be prcNldpJ by Hospilds NHS Folmdalitsn Tn d)nstrAte tW th•y ffl at knast cllh• 0tr4acb¥es li ordèr to be ¢onsklered fur•Jing: Ertwnuro tho quaty of<8 rocer40d ty patwts ¢)¥tt ab(we the NHS skndard Pump atyl SUPE9 inr¥)vakn. Supwn9 th& dfftlopm•nt and oflhe to enth to more the dWati oflhe proj•ct. Flnanclal r•vl•w • Investsrnnt polky WItCh wll ensum that lunds be acc858od prixnpty. slrgicafy aTrJ iJporth"onany a8 demands •ise. In1h• YevpJu$ year. Tnth•$ 8grned to do £1.5j.( trdS the fubjrn fiJn¢fing ofts IWlbe*ng Cwtre. Rainbow UniL
ARK CANCER CHARITY (A Conyany Llmw ty Gu•r4rt•9) TRV8TEES' REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2023 . R•ry•S pollcy At year end the Ct• hekl unrestrKted reserves cl £2.655.917 (2022 - £2,680,58n of vttich É2.381,389 12022- £2.500.000} was dasiW8d by tha TnA8te88. The Reserves Poly subject to an anrthl re¥ltr. at thg and of each firla1 yaar. This r•view 11 tske nto acrjjunl prcioclod LKJgg1 the upccrfnlng year. allon9 trustees to as8•S$ thè adewaty olthè èxislwig r¢sffiie& A¢hl•vemwts •nd p•rfomianc• • ltsln achl•v•m•nts In Smary, Ark Cmr Chwrty's IIVell>eirwJ Contra has wb¥ely impd the commuimty by Fovithng needJ $upF¥t seryicos to cancai pthn succw rafi•th our dpM8e raryo of 59ryl¢es, ¢ourageMent sellin9 WVKaS to ¢r pabwts th• HHFf ar•a. Sorvmig a wid8 ran ofcancgr pabgnts, Ito C•ntre d•monstratss ts ability to calar to dIVee needs. incknling ¢8$1, gyipecolw"¢al. haat8. prDState. oJk>r8¢Aal. upp•r gastrointostinol. lu By offerfng compkner• trw•les akn&sAae conTMttkJnal medical ¢ar•. prcfflotss healing thal erwmpasses bcth tywcal emth¢)l Patignts frc¥)) a cornwphwIYe apwoath that addresses Ireatrrf side effects emoUThwl thalknges. rn. Thew adherence lo NHS guidefmes ar¥J c4rNcai u)leaguos WureS that patient By ¢oThethg and ublsing patlwrt feedbad¢. the centre dgmonstrates Its commitrnent to wtting patlents at the forefront of its ser¥w. apyoath n( cdy irryrovè$ ¢>re wality bul al$0 offgrs in$wJhts to HHFr Highlight•J thrwh varirJJs cage 8bJdies. thè Catr's thtrapw ha¥0 led to poslb've outcomes such as alleviating treatment smle effects, post•00 recovwy. aThJ S'n9 patients Ihrough ¢haltfjngirwJ tr•n•rrts such as rathother4ry. Vlb'maloty. the Cenkn'5 key inwlas ) (Neral l)8ing for cmr paliants. IhrTrJgh offwirwJ effective 10018 to mana9& trenefit thalgn99s and wnoti¢x41 strakn. the Contre contrbutes 10 imwoving palienl$' quakty of lifg Ihair carKeritiumey.
ARK CANCER CHAiurY TRUSTEES. REPORT (CONTINUED) FOR ThE YEAR ENDED 31 DECEIABER 2023 Aehl•v•m•th and p•rlomwnc• Iconlknu•dl Ourwwj summer of 2023. th• cthaiity ddd tr wthrtak• 8 [•r¥th of lh• •xstviq eh8mothwapy Basirytoko Hospitsl. orisinalty de5iW aB a this spaco wa$ repur[Sed lor ¢thrapY durlNJ tho recert parthrn to ansurn Ihe saf of pati8nts aTrl aff. Recognising th• suc£ess of arrangement, the Ath Canw Charty 1$ now embathg on a 8ignilcart r•Jfbl8hment to ueato a nre Colltbxallng a team of eth. the Chty has conthjctod a feasi71 stuty lo plan Ihe rwovation. Th• North Hampshire H05Prtal has appointed As Estate Prr4ecl Manager and cfmlcal Ptwt Manager to Gre8nh Tt has agreed tr) fd•as8 ts £sCQ.0 of match lurwjing wevhxly raiud ttYwJh thelr fundralslng F4adomi by wpporbvo ofth ccer Chaiity. n¥$ wil be directed towards the In to Ilw oThJrAfVJ bewN uvjertth by lh• tharity. we we pl088 to rowt a $gnrfl¢ant to th8 Chgmothwapy Departrn•nt at 8asiry5toke. Sp•offc•lty. have donated a Hdothemi Machine to Jress chalero•s associated ith cmPyucad Feli[ neuropathy {CIPNI M14crfrt SdroMe (HFS}. Chemclher8py. 8 aspecl of Iteatria okn leads to various SKle effects, CIPN Ing a wel known cc¥Kem. This cJxdIb pr•drynAiarlly allts th? and feet of ¢Xrtor patients. resuliing in sev•r• paln. thscomfort, IlwJ. numbness, and balance issue¥. Adtht•. exposwe lo certsin ¢therapY drL uso haTrfts)t syndrthne (HFS). a domwtob?cal corthcffi chwa¢twtsad by r•drn, nunbn•88. 1lTr3. NstedTrJ. a1 dry. pgekrvj skwi i)n the pakn$ sole& CIPN and HFS. We we deThd to e b¢on amoTrJ the firnt to this mathne to thè h¢)sprtal, anowy tt to cortht Its rAYn sludy Ihe efficacy ol the equipmert This SpeCC unit was made Fthsiblo thrwgh thè generous donali¢M by Th• Ethna L8¢xM>Ta ch11th'S FowKlaticffl.
ARK CANCER CHARITY IA Coryany Llmit•d by Gtsarnnl••) TRUSTEES. REPORT (CONTINUE FOR ThE YeAR eNDED 31 DECEIIBER 20Z3 A¢hl•v•m•nts •nd p•rformanc• (contIn} • Fundrlslng acllvlty ov•r th• p•Jty•ar Thrc4Jghout the yw, our dwity fvrKtratsiw efforts hia online plattttms has I01¥•d nsi$tent suppyt from ¥0v$ Commty S.50 nliativo has mathin8d its powlarity. contrfrmthhig to ¢)ur fuThjraiThj sutt8SS. will ovarw th? than5 fiTAncial matters going f[d. An additwal memb8r of thg Trle0 Board Is also In . Furthèm¥Jr•. wo are n th8 F¥r4S5 d hviTrJ a d8rhcaW FunthalsiNJ ma5er to enhance cAJr capabilitigs in tris ¢ru¢ial area. Novernb8r. wwe Ihrw lo H•allh & WeknTNJ Charlty ofth$ Y8¥A¥Md thjring the inougural Greenham Trust Ch81ty Awards Ceremw n Nry. This presb"gious recognition stands as a ts8taryRnt to the meliodous planning by our Charlty aTrJ WdelNJ team. Additionany, it underscm¥ tho LThYdvering SUPPOrt we h8¥e re¢ei¥ed from the genu$ th)nabons contllblrtgd by the public. This award not oyfy ¥kntrA8dg0$ th• sxtstardTrJ athlwem•nts of Chaiity Ixrt also lighlwJNs the positNe extend r heartrel gatitud• to everyw invc4¥•d- our declcated team men)bets. suppyter¥. and the commurnty at largg. Ths rwniiion inspiro8 US to cunknuè our fundraisir#J wkn renewed vi9wr. krK)yn9 that our ¢ollecti¥¢ efforts ar8 makirwj a meanir#JfiA dffieree in the ofthose sorv8. we look fopwaTd to 0)ntinng ourjournoy uo8try 8 Impacl in tho communty. Smal noto In pln9 Ihis repcrt thg dlrecl(vs have tkn atrantay• ofth¥ wnal c4ry¥i95 gxwrytion$ Pded by sect1 415A ol the Comwiey Ad 2rJJ6. )proved by ordor oftho ofth• bo¥d rfTru#•es aNI ¢)n th•tr bth8lfty. ftjl S Fell Trustee
ARK CANCER CHARrri STATUENT OF TII(ISTEES' RESPONSIBILMES FOR THE YEAR ENDED 31 DECÈMBER 2023 The Trustees Ivlts r• aso thè direc$ d th• for ts wpose$ of oxryany lawl are respon81ble f •poring the Trustees. Rwrt aTrJ tha fmancial In c¢dara qth appl¢ab lv aThl Ur1¢d ng(k)m A¢cowng Standards {UnthJ Klr9kn) Grny Attepted AccoLmknng Pracbco). TruBtees 1 not apwovo the financial Stat8M uthss W ar8 sausfjed Ifot tsy a true and falr of the state of affair3 of thg coMnY ¥md ol its w(¥ning re8j5 of resourc, induding its kncorne and gKp•nd#ure. fc that whjd. In Fry>arirvJ these statem, ts Tnle5 are requtred to.. rtiser¥e the methods 8nd prThwl•s ol the Charitles SORP (FRS 102)". make j19M9rS and nting eslimth that •• reayonabte jn[ state appllcable UK AtC4xxty Stwdards {FRS 102) tra¥e bgen fiSlowed. subFd to any materfal departur•s 15$dd and explained kn the fIrClaI ststements; rry¥e the flnancoal slemwrts on 90ry c4ncom ba$s wless it 1$ Inwopri8te to pr•stThe that th6 the transactlons discknse witt) reasonth accurw * ary tima thè fmanrial of the Company enable to ensure that th• finan¢Tr81 Slatements compty Ihè Compani8$ Act 2006. Th•y 0 responsible for SaIarth3 the 8559ts ol the aThl herK8 fortth'ng réasonabb $lèps for preventson detsctKin of fraL•J a¥J other irrg¢Jul•iis. Approv•d by orthrofthe 01t bo¥d Trust08S *MI * on bthall ty.. S Fell Tru3ts• spoil. .Iql2Ltr Page 8
IA Coryany Llmlt•d ty Guarnnt••) INDEPENDENT EXAMPR8 REPORT FOR THE YEAR ENDED 31 DECEIW 2023 Ind•p•ndent Examlnerf R•wt to th• Trust••s olArt Canc•rCh¥lty Ilh• Comp•ny? I report to the tharmy TnAl•e8 my examiwkn of the accou of ts COrTv br the year ended 31 Decqmb•r 2023. R••ponslblMtl•s and Basls ol R•port As th TnJst•es of tha Ckvnpany {xl its fiy the ofc¢xnpany law) y<Ju arg r88p¢Ki¥iLqe for the preparatton ofth8 accounts in ac£¢Kdonce with lh8 1eWrnts d the Act 2006 Ilhe 2006 Ac). Having satisfd Metr that the of tt c we not to be audad wder 18 of th8 2006 Act are for indwrrtlent examinatK¥). I rep)rt in $pert of my &x)inl0n of tho Companrfs accounts carried out under sedion 145 olihe Charities Ac 2011 llhe 2011 Acn. In c'n9 Cmrt my exomination I hav• followed the Diroclions gvon ty ts CW cn3$10n (Y¥J¥r seclion 145(S)Ibl oftho 2011 Act. Indep•nd•nt Exanth•¢• Statsment I have comwed my examinatif. I confm that rn terS hav8 c to my cne¢lA)n wlh trle exarnination givry m¢ t¥è'. or any requirement that thé accourts fairf vie is nc4 a ¢mstdored a$ part of an indep9ndent exwnInati. or tho acccmmts hav• not Ihe m•lhfts and Frfin¢ipl•s ofthe Statoment of Recommended PraciK• for xvJunliry and reportirvj by charitieB lappfjcatAe to chle9 preparing Iheir accounts in acrdanC ¥hth tho F4w¥ial Rapthg st¥d wlablg kn lh8 UK and Republic of Ireland (FRS 102)]. I have no cJJn¢ems wd ha c(xno matters in connerkn the eMnhMiion to whlch attenb.on 8h¢)uld be drawn in this reFth in ¢xder to enable a wopor understan(*ng of the accounts to be
ARK WICER CHARITY IA Cryny Lknlt•d by G4want••l INDEPENDEKf EXAMINERS REPORT ICONTINUEOI FOR THE YEAR ENDED 310ECEMBER 2023 Th1$ rIp * mad• sow to thè Tnxteas, 88 a b. in acOXd 4th Part 4 d tho Chwlties (ACCnts arKI Repjrtsl R•gulatiM$ 2008. W Twoth has bfj so thal l rnight #ate to thè Comp8nYs Tru5t8es tIb) mattqfs l am requi1 to slate to Ihem in Sn Indopend•rt Examinels ReFxI and for no other purpose. To the f&t •xlwrt pwmitted by law. l ¢> Thx wl crf assume responslLIUty lo yone othw than Crynpany the cor1v$ Trustées as a bw. my TAyxk or for Ihls rwL 109 ) 2£)l Mark Thcin5 FCA ShawGlbbs IAudlQ Lknll*d Unl¢)n Roal FarnM Surrey Gug TrT Page10
ARK CANCER CHARITY IA Company Limlt•d by Guarnt••) STATEMENT OF FIMAPICIAL AC7MTIES {INCORPORATING INCOME AND EXPENDITURE ACCOUND FOR THE YEAR ENDED 31 DECEMBER 2023 Unr••trlrt•d funds 2023 T)lal nds 2023 Total 2022 Com• froTh." Donabon$ and IW$ Othertrading athbes Investrnerts 37,416 301175 69.541 37.415 30,078 69,541 117.L 24,695 13,026 Total knc¢)m• 137.031 137.031 154. 730 Exp•ndkn on: Raising fvnds Chwilable •th¥ili•g 1614 139.087 2,614 139,087 3.159 201.626 Totsi •xp•ndlturn 141,701 141.701 204.785 Ngt n•rn•nt In fund 14.$70) 14.6701 (50,055) Ro¢onclliatw)n of fvnds: Tota fimds brtwhl Net rnovement in ftvKIs 1660,587 . 2,660.687 14.670) 146701 1710,642 ¢,055) Tow fvnd¥ ¢•ryigd forwArd 2,66517 2.164917 2,660,587 The nolas t)n page$ 1410 28 fomi wt ollh88e st*eMts.
ARK CANCER CHAiirrY IA Cwnp•ny Umll•d ty GuiThnt••> REGISTERED NUM8eiL. 08240913 LANCE sTrEEr AS AT 31 OECEMBER 2023 2023 2tr22 Flxgd amots Tang4bl8 asséts Curr•nt 11 12 13 9,053 I2016 831,506 Inveslmerts Cash at bwk harbj 10S8.$96 677.932 1746.366 1842.575 14 197AS8) (183,788) N•t ¢urff•nt 48sats 2658, T87 Total as••ts Gurr•nt 1bHS 2MS,918 2.660,58T N•t ••s•ts •xcludlng p•nsl¢)n •¥¥•t 1664918 Z660.587 Tot•1 n•t I•ts 2.666.918 2,660.597 Ch•rlty fvnds Restricted frthJ8 Unroslriei•d IwKts Is 15 2.660,587 Total 14nd 1656.918 2.66Q.58T Pa98 12
ARK CANCER CHARITY IA Comp•ny Llmlt•d by Guarant••) REGISTERED NiKA8eR: 08240913 BALANCE SHEEf ICOMTINUED) AS AT 31 DECEIABER 1023 Th• COMP was Ontilled to exen4XKMI fmm ¥Jer 4TT afth• Cofflpanles Act 2006. The members have Th)t require(l thè cxryary to otthn for ts yw in qstion accLYdance th thè small conyii•8 r•gm•. Th• rYw•1 st*•m•nts wffo apK¥owJ auNiTed flx i5SU8 Trusts8s and slgned their behdf by.. S F•ll Twst Spkii iolql24 Pag• 13
ARK CANCER CHAIIITY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEM8eR 2023 G•ner•l IAfom Canw Chwbty (fomty Cancw rs • piiv compry. limit by guarantse thwt ¥h¥e $tal irt4rpryed in Ils registwod offiGe adthgss h The Ark Cce Centre, Dinv•Yxxli• ttri¥è. Ba3gStOke. Hwnpshye. RG24 9NN. A¢counllng pokl 2.1 Ba•ls ol prnyratk)n o(Ilnancl•l strt•n The flal st•m•ts h8¥8 be tAvlh Ih Char#s SORP IFRS 1021 . Anting and ty Charttle8.' Ststemwrt ¢ RK0mm4Od Practic• applicabl8 to eharthes preparing thr accrtS in C(wan¢e tyth the Financ Reportirg Standard applicablo in thg UK and R•pubk of Ireland IFRS 102) leffocbve 1 JaNwy 20191. tr Financial Rèpth"ny StsTrJard appl¢•bl• fft the UK cl {FRS 1(r2) the CoNyi•i kt 2006. Carur Chty me d•finiticffl of a benefit entity dar FRS 102. Assds aTrJ li1118$ are inliaty recognised at IM$tOfical c¥t or Vakn un19SS Oth8rnige 8tated in the relevant 12 Incom• The recognttlon ol I frcm lewies 18 on 8staNishry entiuorrt the kvobollty of ¢elpt IIKI lo tstim ilh suffiaent thg arn Irats. Ed¢t of eniuement to a legacy exists Ythen the Company $fft"t ewd•nce that a grfl has been left to them kTh7hl8dg8 of Ihe exi#m of a vald ar¥J the dgah of b8nefactorl ar th8 eYertor is satisffied that Ihe Pr 111 not be reqwr8d to sabsfy daims in Ihe •ststa. RiX•Pt of a legacy must be rewised when it is wobai49 that It ill be recefjved and the falr ¥4lue ol thè afflrnt f&vatIe. wll genwaly b8 ts exptrxod cath am¢yJnt to bo distrtthd lo tt use of Iho C(ynpwty of it)) 1$ 0b1t48 that ben•fft be measured relabty. cordarte with the ch•eS SORP {FRS 102). yrwal Yonte tirn• 18 1 reciwNd rof tho gift to ihe Company whlch Is the amount it would h•v0 ten rylling to pay to obtain saNices or lacmleg of ew1valer benefft mwket,. a ¢W'a is th recY4Thsed wi expendth in Ihe of recelpL i¢• is receivable. Page 14
ARK CANCER CHARirY IA Comp•ny Und ty Guarnnt••l NOTES TO THE FINANCIAL STATEIIENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Aceountlng pollcl•s l¢ontlnu•d 2.3 Exp•ndltur• ExrrMtwe is 0¢ tlwa is a ¢tr IgatiOn to transfvr aconomic benefit ID a tr¥rd patty. prcable that a trarfr of economic benefits will b8 required in $8ttJ8ment the am0 of tho otAigion Can bo rn1¢d lIablY. Expenditurn 1$ dassifiod by aclNty. Th o)sts of eath "¥rty are made up ollhe t1 ol c>Jsts and shared costs, induding supp¢xt costs invLi8d in undgrtathg a¥th activly. &'recl ccts attrfrtats to a slngle aclivlty ar• allc¢ated dlreclly to that a¢tivity. Shared &)sts wlM¢h conlritrth to More than one acbvty and sw)p costs vthich we not atlribJtabl8 lo a siThJJe actlvty are apportionod befv those acllvlties on basis conslstent with the use of resour¢e8. Cefttr aff costs are alltxated on th¢ b18 of b'me 8pert, dèyeuatson &wge$ axd ¢)n the ofthe a$t'S use. ExpeTrjitO on raiNJ Irthths Irred by tho Company to rai8e furKls its ExpencltLTh on thaiitable aclivthes is incur1 on direcfjy uTrJ8rWng I1 athifies whkh fither tho Comparrfs thItiVes. as wll as arry asKKiaW supm costs. Grants payable are rtr9ed in thè year the offer 1$ made tx¢èpt in those cases where tha offer is conditional. such reccgised as exFerMlilure thlw the dIorts attathing are lfillad. Grants offw8d subA'•cI to cfyThdth"¢)ns have not m8t at tho year end not•d ¢>Jmmitmert bLrt nol atXrU 8$ eXptrndrtu. 2.4 Int•rn•l v•¢•l¥ab Int•r fvnd$ W on knht is indudgd 7then rKe1val and amowrt be measured reliatty by tt)e Company.. this is rA)mwly UPDn ThAificatson of the wrterest paid or payable by the 2.S TangllA• • and dqprnckntkni Twffjlble ffixed as ar8 ffecow4s•d at OXL Aft•r regraI1¢n. the cost model, tangible fixod assots aro mBaswed at cost 18ss XCUMatod (W•Jation any accumulal•d inpairTrt losM$. All ¢o#s rKw•d lo a tanyble fixed asset into it8 Snlended workir4J corKIitKn sho1 be induded in measuremert ofc06L At eath date the C¢mpwy assesses **ther there 1$ any dlitin of imwmwnt. If su¢h vmlicalion èxists. th• r•c<rAfabl• of the assat is determined to be lh8 hwjhar of ils fair val less ¢osts to seH and tts T4alue n use. An tywaimient loss Is recogrusod v+ttero the carrying amount DeFcIalI0ft 1$ tharged so 09 to ol tangblo f• assets lesg thw dl1 valu• over Iheir eslim&ed usoful live& cLYnpT - 8trWI bags Pag•15
ARK CANCER CHARrrY (A Conyy Umlt•d ty GrInt••) MOTES TO THE FINANCIAL STATEIIENT8 Foft THE YEAR ENDED 31 DECEMBER 2023 Ac¢ounOng poll¢le• {Mntlnu•d) 18 0010rn Trade other debkns e at sfjiUem8nt •))ourrt aftw Irade discount off41. Prepayinents ar• valued at ts amowrt prepaid net of tradè th$cl)ts d. 17 Curr•nt •M•l Inv•skn fr(¥n the d of op•nkng ofthe dowsit tlt. 2A C•8h at bank and In hand C•sh at blnk )d w) Iwxl •xyJ8s cath xl ¥lx14wm thwid wllh a 8hort mattty of three morrttrLs the d of acw1sitft ty opthng of Ihè dtyosi or simlar 19 Lknblllll•s and provl#l¢) Liabliliès are recognls8d when there is an Oblig at Ihe Balance Sheèt date as a r¢&At of a past evenl bt is probabk that a transf•r af •conomK benefft w1 bg rgqLirad in selU•mènt. and th• amourrt Llabdilios are rewis•d * the WKXmt that the C•nY dpaleS it pay to settte th8 debt or 110 FlnaKlal Imtrw The CoThyany +xty has assets arxl rla1 kabllies of a kind Itmt qualrty a& bas flnancK41 inatrumwts. Ba¥c f#wKial recognlsed at transac value and bsequenty moaswod at their sothmert ue Mlh tm oxcoptw of bank logns ¥thich are 2.11 Fd •c¢ounll G•nw funds we urwestrict•d furth w• availabl• lor use at the discrntion of th8 Trusknes in fjJrtherarKe ofts ciyer¥e8 of cY arwj T*IMth have nDI b••D desigrAted for other purposes. Thè am use of •ath da8ythI knt is thè rth to finan¢ Pa9• 16
ARK CANC&1 CHARITY (A Comp•ny Umlt•d ty Gu•fknl NOTES TO THE FINANCIAL STATEPAENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Incom• from dr•natlons and 1•gacI•s Total fund• 2023 fund$ 2023 Donattons Legacias 28.125 92SNJ 28.126 0.290 37,415 37,416 IrMKlad in donatirm 1$ £17.54012Qtt. £21.024) emat¢d as the of8*i&s dorot•d. Tot8f lunds 2022 2022 DMalion$ Ltyacie$ Grants 46.109 70,9C 46,109 70.9C 117,(9 117,009 T¢tsl funds 2023 fund• 2023 30,075 30.076 Tot81 runds 2022 2022 24.095 24,895 p 17
ARK CANC£R CHARITY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Unrestrfcted funds 2023 Total lund• 2023 69.541 69,$41 Y22 2Q2 13.026 13.026 Exp•ndkn ¢n f*l•lng funds iknrpstrlct• Totsl 2023 2013 Orflne dcfiatlon hes 216 216 2.398 2.614 1614 Page 18
ARK CANCER CHARITY IA Company Umlt•d by Gunnt••) NOTES TO THE FINANCIAL STATEMEKrs FOR ThE YEAR ENDED 31 DECEMBER 2023 Exp•ndXw• on rnlthg fvnds leonllnwdl Total fvnds 2022 runds 2022 43 216 43 2t6 Onh'm donati foes Costs of m• piizes 3. 159 3.159 Antysls of •xp•ndurn on ¢h•r#abl• xlivKI• Actlvltles Grant uTrd¢rtak•n fundlng of dlrocdy actfvlUe¥ 2023 Support Total fund¥ 2023 2023 Diroct ¢0918 108245 10,366 20,476 139.08f fynd of Support etivrfies 2022 T¢81 funds 2022 22 Llr8d costs 167.539 34.087 201.626 IrKlwled kn suprhJt sts is £17.54012022- £21.0241 fjstlmed as cost of salwies donatéd. Page19
ARK CANCER CHARITY NOTES TO THE FINANaAL STATEMENTS FOR THE YEAR ENDED 31 DEGEMBER 2023 Anatysts of •xp•ndltsr• chrfiaW• actr¥knInurn Totsl ffd$ 2023 2022 Fee8lsubscrlptions Advwbsing and wonyJlK>n Misollaneous ¢os 3.624 487 6290 R•charg•d 8tsy co81$ Staikngry 21.024 1.189 706 Thon 11.976 6.7 20.476 34,087 An•ly#l# efgrnnts 13ranty In•titutloths 2023 Totsl funds 2023 Grwts to Hamre HO¥815 NHS Tn•l Ihè W2llbewig C&re 10.388 1Q.366 Grnnls to 2022 2022 Grnnts lo Hampshn P105pas NHS Tru81 kn vrKAtafth• V4Wlbery C•ntre 167.539 167,539 P•30 20
ARK CANCER CHARITY IA Con¥•f•y Umlt•d by Gu¥ants• NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 ¥vJepond•rt oxaminefs rwrnJrrkn to 1thdanI ownin8r fa• of £327012022. 10. TnMi••¥' r•ftwn•rntlon and •xpMM• Dwng Ihe yr erthd 31 lknbW2l3. no TnMt•• •xp•nw hav• boen incurrod (2022. ÈNIU. P4• 21
ARK CANCER CHARITY Corywny uffltt by Guarnnts•} NOTES TO THE FINANCIAL STATEMENrJ FOR YEAR ENDED 31 DECEMBER 2023 11. Tarylbk b7x ass•ts C¢mputgr equlpm•rt Co•t orYalu4llon At 1 Janu¥y 2023 Additions Di8POSa 6,33S At 31 Dmber 2023 gM69 Deprttlaiion At 1 J•nwi 2023 Chwge for th ye (kn dsposal$ 4084 1.125 At 31 2023 2,659 M•t l)ook lu• Al 31 D¢e¢n*w 2023 7.010 At31 0enr2022 12. D•btorn 2023 2022 9.13B 9,053
ARK CANCER CHARITY IA Gompany Umltsd ty Gurattte•) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEM8ER 2023 13. Curr•ne asset Inveslmonts 2023 Tem) depos accounts 2,068,596 2.CV2,0115 14. Cr•dltors: Amounts falllng du• TAlthln on• year 97A58 t83, T88 P•ge 23
ARK CANCER CHAIOTY NOTES TO THE FINANCIAL STATEME14TS F(* THE YEAR ENDED 31 DECElJlaER 2023 16. Stst•m•nt OlndS Stst•m•nt oltsnds-¢uvr•nt year Balane• al 31 Balanu at 1 January 2023 Incomo Eyndltsr• 2023 Unr•gtrlcl•d funds D•slgnatsd funds Th• Wdlbairy Cantre Ral)tiw Unit Proiact Im.OOD 1.600,000 110.366 919.634 {108.246) 1.391.76S {118,6111 I381A89 G•n•Tal fund¥ Genernl ILmds 160. 137.032 {23,09 274.52• Tot•1 Unr••trlct•d fund• 1660.58T 137.032 1141,7011 2,6$5,918 P• 24
ARK CAMCER cTrwiirrY IA Company Llmll•d ty GuaTants•) NOTES TO THE FINANCIAL STATEMEiirs FOR THE YEAR ENDEO 31 DECEMBER 2023 15. Stalement olfunds Icontlnued) Stalemert ol funds. prlorymr 8818ncg 81 31 Trnnsfe EL¥mb8r 20Y l January Unrn¥trlct•d fvnds l>•slgnat•d fvnd8 The WeIng Centre Rainb(MT Urmt Propcl I.5.Cly1 I.590.Cts) I,Lxk),Lx i.000.L 2500.1 2.500.OC Gèftvrnl funds 2710.642 154.T30 (201.785) {2.sL.OLj 160.587 Tot•1 Unrn•tr1 fund# 2,710,642 154. (204.785) 2,66Q7 PJe 25
ARK CANCER CHAIIITY NOTES TO THE FIIIANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2Q23 1& ollund¥ Summary oftsnd¥. curntyoar Balan at 31 Balanc• at 1 January 2023 Incom• Exp•ndltur• Oesignated fffids General fvnds Isoo,000 160,687 {118.811) 2,311, (23,0gD) 274529 137,032 1660.587 I3732 1141.701) 2.655,918 Sunxnary of fvnrfs. prlory•r Balan at 31 l Janu 2022 Clesiglated Z710,642 f54.T30 (204.78S) (2.500.QX)) 160.587 2710.642 154.7 (204.785) 2,660,587 17. AN1& ot not assels b•lw•w fvnds fvnds 2L12J fvnd• 2023 Tble fred a8ts Cuffent assd$ Cf•litors due NK* 7,010 7.010 2.746.366 &748,360 {97.458) 197,4681 2.655,918 2.656.918
ARK CANCER CHARrr (A Company Urntt ty Gurnnts•) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 18. Op•rdng l•as• ¢onwnltmonts At 31 t)ecember 2023 Cc•npwy hwj Ixxnmitrnents to rn• mkimum l¥se pasffnents )n4anc•latl• cpwaing lus8s •s frknts: 2022 Equlpm•nt )t lalw than 1 yew Lrth 1 yew and not lal8r 5 ye¥s 1.250 1.133 1,487 2.384 2A83 3,871 19. M•mb•rs' Ilablllty Eath mgmbgr of the thrilable CcThp8ny dkoS to contsknuk tt) the assets of the Company in th• event of 6t belng Wnd vkniJ8 h8lsho is a mèmbw. or wthin year aftèr Iwl$he ceases lo be member. suth amount as nw b¢ rowr•J. rw)t £1 for th& dg1)ts l1obm•s CC4ttfacied b8forg helsh• to bè a member. R•lit•d party tTans•ctlons 21. Post balanc• ¥hMt•v•nts SirKe thfr balarKe sheet date. Ihe cha of a furtrw £95,000 legacy was received in Jly 2024. Controlllng p•rty trirJ the year. tt)8 chkn was Lntsthe d1he Tn*tee¥. Page 27
NOTES TO THE FINANCIAL STATEMENTS FCI? THE YEAR ENDED 31 DECWER 2023 C¢ynmon Tnjst confinn&ts rt wrAAY matdFfwd thations for tha Ath Chaiity rf th• thaticry were put thrcmjgh their Fr&mfr&(>anl' pta. Ihts evofved knlo The Grt Exnge. The matsh funding was Set on a basis ofa 1.1 ratio to maximum of£500.C(thJ.The Axk Chty reaed thls m8tClfvndIng goal in NfNomber 2017. The mthed fundng Pa frryn Greenh•n Comnw)n Tnt thill be r•*ed to the tharity rtteipt of a c¢py COM Crytificale. Ralntthv ithf¢ refurbislvnwrt Frfolt 2024. Page 28